Current status of rotational atherectomy

被引:99
作者
Cavusoglu, E
Kini, AS
Marmur, JD
Sharma, SK
机构
[1] Mt Sinai Med Ctr, Cardiovasc Inst, Cardiac Catheterizat Lab, New York, NY USA
[2] SUNY Brooklyn, Hlth Sci Ctr, Dept Med, Div Cardiol, Brooklyn, NY USA
关键词
rotational atherectomy; calcification; complex lesions;
D O I
10.1002/ccd.20081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite the increasing use of percutaneous transluminal coronary angioplasty and intracoronary stent placement for the treatment of obstructive coronary artery disease, a large subset of coronary lesions cannot be adequately treated with balloon angioplasty and/or intracoronary stenting alone. Such lesions are often heavily calcified or fibrotic and undilatable with the present balloon technology and attempts to treat them with balloon angioplasty or intracoronary stent placement often lead to vessel dissection or incomplete stent deployment with resultant adverse outcomes. Rotational atherectomy remains a useful niche device for the percutaneous treatment of such complex lesions, usually as an adjunct to subsequent balloon angioplasty and/or intracoronary stent placement. In contrast to balloon angioplasty or stent placement that widen the coronary lumen by displacing atherosclerotic plaque, rotational atherectomy removes plaque by ablating the atherosclerotic material, which is dispersed into the distal coronary circulation. Other lesion subtypes amenable to treatment with this modality include ostial and branch-ostial lesions, chronic total occlusions, and in-stent restenosis. This review discusses the technique and principles of rotational atherectomy, the various treatment strategies for its use (including adjunctive pharmacotherapy), the lesion-specific applications for this device, and the complications unique to this modality. Recommendations are also made for its use in the current interventional era. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:485 / 498
页数:14
相关论文
共 81 条
  • [31] PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY OF CHRONIC TOTAL OCCLUSIONS - PRIMARY SUCCESS, RESTENOSIS, AND LONG-TERM CLINICAL FOLLOW-UP
    IVANHOE, RJ
    WEINTRAUB, WS
    DOUGLAS, JS
    LEMBO, NJ
    FURMAN, M
    GERSHONY, G
    COHEN, CL
    KING, SB
    [J]. CIRCULATION, 1992, 85 (01) : 106 - 115
  • [32] Kiesz RS, 1999, CATHETER CARDIO INTE, V48, P48, DOI 10.1002/(SICI)1522-726X(199909)48:1<48::AID-CCD9>3.3.CO
  • [33] 2-P
  • [34] Kini A, 2000, J AM COLL CARDIOL, V35, p87A
  • [35] Reduction in periprocedural enzyme elevation by abciximab after rotational atherectomy of type B2 lesions:: Results of the Rota ReoPro randomized trial
    Kini, A
    Reich, D
    Marmur, JD
    Mitre, CA
    Sharma, SK
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (06) : 965 - 969
  • [36] Kini A, 1998, J INVASIVE CARDIOL, V10, P169
  • [37] Kini A, 1999, CATHETER CARDIO INTE, V46, P305, DOI 10.1002/(SICI)1522-726X(199903)46:3<305::AID-CCD9>3.3.CO
  • [38] 2-L
  • [39] Kobayashi Y, 1999, CATHETER CARDIO INTE, V46, P406, DOI 10.1002/(SICI)1522-726X(199904)46:4<406::AID-CCD4>3.0.CO
  • [40] 2-Z